NFKB1 and metabolic syndrome: In this study, the levels of the activators of the NF-Kβ signaling pathway including FFAs (Table 1), g-Alb, MGO, AGEs, IL-1β, glycated and oxidized LDL (Table 2), as well as expression of Nf-kβ (Figure 1) were higher in the metabolic syndrome group than in the normal group.